EP1183011A4 - Method of treating angina and/or anginal equivalents, and pharmaceutical compositions and kit related thereto - Google Patents

Method of treating angina and/or anginal equivalents, and pharmaceutical compositions and kit related thereto

Info

Publication number: EP1183011A4
Authority: EP; European Patent Office
Prior art keywords: anginal; equivalents; pharmaceutical compositions; treating angina; kit related
Prior art date: 1999-05-14
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP00932314A

Other languages

German (de)

French (fr)

Other versions

EP1183011A1 (en

Inventor

Dennis I Goldberg

Kevin Jon Williams

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Esperion LUV Development Inc

Original Assignee

Esperion LUV Development Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-05-14

Filing date

2000-05-12

Publication date

2005-01-19

2000-05-12 Application filed by Esperion LUV Development Inc filed Critical Esperion LUV Development Inc

2002-03-06 Publication of EP1183011A1 publication Critical patent/EP1183011A1/en

2005-01-19 Publication of EP1183011A4 publication Critical patent/EP1183011A4/en

Status Withdrawn legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Hematology (AREA)
Anesthesiology (AREA)
Biomedical Technology (AREA)
Pulmonology (AREA)
Neurosurgery (AREA)
Dispersion Chemistry (AREA)
Endocrinology (AREA)
Hospice & Palliative Care (AREA)
Obesity (AREA)
Neurology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

EP00932314A 1999-05-14 2000-05-12 Method of treating angina and/or anginal equivalents, and pharmaceutical compositions and kit related thereto Withdrawn EP1183011A4 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US13414099P	1999-05-14	1999-05-14
US134140P		1999-05-14
PCT/US2000/012962 WO2000069412A1 (en)	1999-05-14	2000-05-12	Method of treating angina and/or anginal equivalents, and pharmaceutical compositions and kit related thereto

Publications (2)

Publication Number	Publication Date
EP1183011A1 EP1183011A1 (en)	2002-03-06
EP1183011A4 true EP1183011A4 (en)	2005-01-19

Family

ID=22461948

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP00932314A Withdrawn EP1183011A4 (en)	1999-05-14	2000-05-12	Method of treating angina and/or anginal equivalents, and pharmaceutical compositions and kit related thereto

Country Status (6)

Country	Link
EP (1)	EP1183011A4 (en)
JP (1)	JP2003508349A (en)
AU (2)	AU773385B2 (en)
CA (1)	CA2373681A1 (en)
HK (1)	HK1044897A1 (en)
WO (1)	WO2000069412A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6982251B2 (en)	2000-12-20	2006-01-03	Schering Corporation	Substituted 2-azetidinones useful as hypocholesterolemic agents
US7071181B2 (en)	2001-01-26	2006-07-04	Schering Corporation	Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
IL156445A0 (en)	2001-01-26	2004-01-04	Schering Corp	Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
SI1355644T1 (en)	2001-01-26	2006-10-31	Schering Corp	The use of substituted azetidinone compounds for the treatment of sitosterolemia
US7053080B2 (en)	2001-09-21	2006-05-30	Schering Corporation	Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
US7056906B2 (en)	2001-09-21	2006-06-06	Schering Corporation	Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
DK1429756T3 (en)	2001-09-21	2007-03-19	Schering Corp	Treatment of xanthoma with azetidinone derivatives as sterol absorption inhibitors
GB0207653D0 (en) *	2002-04-03	2002-05-15	Lamellar Therapeutics Ltd	Methods of using lamellar bodies for therapeutic purposes
US20040009216A1 (en) *	2002-04-05	2004-01-15	Rodrigueza Wendi V.	Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease
US20040092499A1 (en)	2002-11-06	2004-05-13	Schering Corporation	Methods and therapeutic combinations for the treatment of autoimmune disorders
WO2004081002A1 (en)	2003-03-07	2004-09-23	Schering Corporation	Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
ATE418551T1 (en)	2003-03-07	2009-01-15	Schering Corp	SUBSTITUTED AZETIDINONE DERIVATIVES, THEIR PHARMACEUTICAL FORMULATIONS AND THEIR USE IN THE TREATMENT OF HYPERCHOLESTEROLEMIA
CN1756755A (en)	2003-03-07	2006-04-05	先灵公司	Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
US7459442B2 (en)	2003-03-07	2008-12-02	Schering Corporation	Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
US10517883B2 (en)	2003-06-27	2019-12-31	Zuli Holdings Ltd.	Method of treating acute myocardial infarction
GB0322448D0 (en)	2003-09-25	2003-10-29	Lamellar Therapeutics Ltd	Using lamellar bodies to modify linear biological macro molecules
US9445975B2 (en)	2008-10-03	2016-09-20	Access Business Group International, Llc	Composition and method for preparing stable unilamellar liposomal suspension
US9993427B2 (en)	2013-03-14	2018-06-12	Biorest Ltd.	Liposome formulation and manufacture
US20180177724A1 (en) *	2015-07-02	2018-06-28	The Regents Of The University Of California	Site-targeted nano-liposomal nitroglycerin therapeutics
CN109902357B (en) *	2019-01-31	2020-06-02	东南大学	A Sensitivity Analysis Method for Dynamic Response of Smooth Nonlinear Structures with Complex Variable Differences
CN109821021B (en) *	2019-03-27	2020-12-25	复旦大学	Use of P-glycoprotein inhibitors in CDX-modified drug delivery systems
WO2022178318A1 (en) *	2021-02-18	2022-08-25	Beren Therapeutics P.B.C.	Methods for the treatment of familial heterozygous and homozygous hypercholesterolemia with cyclodextrins

Citations (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS59137409A (en) *	1983-01-27	1984-08-07	Green Cross Corp:The	Benzodiazepine compound fat corpuscle preparation
DE3339861A1 (en) *	1983-11-04	1985-05-15	Bayer Ag, 5090 Leverkusen	Medicinal formulation containing dihydropyridines
US4976964A (en) *	1985-04-27	1990-12-11	Bayer Aktiengesellschaft	Medicament formulation containing dihydropyridines and a process for its preparation
EP0560138A1 (en) *	1992-03-10	1993-09-15	Bayer Ag	Drug formulations by liposomes and the process for their manufacture
WO1995023592A1 (en) *	1994-03-04	1995-09-08	The University Of British Columbia	Liposome compositions and methods for the treatment of atherosclerosis
DE19536245A1 (en) *	1994-09-30	1996-04-04	Juergen Dr Regenold	Pharmaceutical compsn. for spraying as drops
US5653998A (en) *	1994-09-12	1997-08-05	Bayer Aktiengesellschaft	Injectable liposomal pharmaceutical preparations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE78158T1 (en) *	1985-05-22	1992-08-15	Liposome Technology Inc	METHOD AND SYSTEM FOR INHALATION OF LIPOSOMES.
US5510389A (en) *	1994-03-02	1996-04-23	The Procter & Gamble Company	Concentrated acetaminophen solution compositions
US5674488A (en) *	1994-10-07	1997-10-07	Reich; John J.	Method for prevention and treatment of hyperchlolesterolemia by in vivo hydrogenation of cholesterol
EP0863748A4 (en) *	1995-10-11	1999-11-03	Kevin Jon William	Liposomal compositions and methods of using them

2000
- 2000-05-12 EP EP00932314A patent/EP1183011A4/en not_active Withdrawn
- 2000-05-12 AU AU50053/00A patent/AU773385B2/en not_active Ceased
- 2000-05-12 WO PCT/US2000/012962 patent/WO2000069412A1/en not_active Ceased
- 2000-05-12 CA CA002373681A patent/CA2373681A1/en not_active Abandoned
- 2000-05-12 JP JP2000617871A patent/JP2003508349A/en active Pending
- 2000-05-12 HK HK02106533.9A patent/HK1044897A1/en unknown
2004
- 2004-07-27 AU AU2004203419A patent/AU2004203419A1/en not_active Abandoned

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS59137409A (en) *	1983-01-27	1984-08-07	Green Cross Corp:The	Benzodiazepine compound fat corpuscle preparation
DE3339861A1 (en) *	1983-11-04	1985-05-15	Bayer Ag, 5090 Leverkusen	Medicinal formulation containing dihydropyridines
US4976964A (en) *	1985-04-27	1990-12-11	Bayer Aktiengesellschaft	Medicament formulation containing dihydropyridines and a process for its preparation
EP0560138A1 (en) *	1992-03-10	1993-09-15	Bayer Ag	Drug formulations by liposomes and the process for their manufacture
WO1995023592A1 (en) *	1994-03-04	1995-09-08	The University Of British Columbia	Liposome compositions and methods for the treatment of atherosclerosis
US5653998A (en) *	1994-09-12	1997-08-05	Bayer Aktiengesellschaft	Injectable liposomal pharmaceutical preparations
DE19536245A1 (en) *	1994-09-30	1996-04-04	Juergen Dr Regenold	Pharmaceutical compsn. for spraying as drops

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Section Ch Week 198437, Derwent World Patents Index; Class A96, AN 1984-229071, XP002306579 *
See also references of WO0069412A1 *

Also Published As

Publication number	Publication date
EP1183011A1 (en)	2002-03-06
AU2004203419A1 (en)	2004-08-19
AU5005300A (en)	2000-12-05
HK1044897A1 (en)	2002-11-08
WO2000069412A1 (en)	2000-11-23
JP2003508349A (en)	2003-03-04
CA2373681A1 (en)	2000-11-23
AU773385B2 (en)	2004-05-27
AU2004203419A2 (en)	2004-08-19

Publication	Publication Date	Title
EP1183011A4 (en)	2005-01-19	Method of treating angina and/or anginal equivalents, and pharmaceutical compositions and kit related thereto
GB0014969D0 (en)	2000-08-09	Novel method of treatment
IL160933A0 (en)	2004-08-31	Methods and compositions for treating ?cap associated diseases
DE60130043D1 (en)	2007-09-27	Primer composition and coating method
DE60132732D1 (en)	2008-03-27	Primer composition and compound method
GB0117054D0 (en)	2001-09-05	Methods and means for modification of plant characteristics
GB0110288D0 (en)	2001-06-20	Composition and treatment method
ZA200108446B (en)	2003-08-27	Novel method of treatment.
AU2001232201A1 (en)	2001-08-14	Pharmaceutical compositions and methods for treating rheumatoid arthritis
ATE355062T1 (en)	2006-03-15	RETARD PREPARATIONS OF CHINOLONE ANTIBIOTICS AND METHOD FOR THE PRODUCTION THEREOF
IL153359A0 (en)	2003-07-06	Peptides, compositions and methods for the treatment of burkholderia cepacia
GB0128495D0 (en)	2002-01-23	Gaming system and method of operation thereof
HUP0400296A3 (en)	2008-03-28	Method for preparation of 10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepine-5-carboxamide and 10,11-dihydro-10-oxo-5h-dibenz/b,f/azepine-5-carboxamide
GB0126643D0 (en)	2002-01-02	Composition and process
ZA200203435B (en)	2003-06-25	Method and compositions for treating pulmonary diseases.
AU6137801A (en)	2001-11-20	Method and composition for the treatment of angiogenesis
IL161057A0 (en)	2004-08-31	Composition and method for minimizing or avoiding adverse effects of vesicants
AU5565401A (en)	2001-11-07	Materials and methods for the treatment of depression
GB0008921D0 (en)	2000-05-31	Method of treatment
GB9924752D0 (en)	1999-12-22	Method of construction
GB2346869B (en)	2002-09-04	Improved carton and method of construction therefor
AU2002342188A1 (en)	2003-06-23	Methods and compositions for treating flavivirus-mediated disease
ZA200007816B (en)	2001-07-16	Composition and method for the treatment of concrete and masonry.
GB0107033D0 (en)	2001-05-09	Method and composition
AU2002353915A1 (en)	2003-05-26	Methods and compositions for treating rotavirus-mediated disease

Legal Events

Date	Code	Title	Description
2002-01-18	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2002-03-06	17P	Request for examination filed	Effective date: 20011213
2002-03-06	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
2002-03-06	AX	Request for extension of the european patent	Free format text: AL;LT;LV;MK;RO;SI
2002-04-10	RAP1	Party data changed (applicant data changed or rights of an application transferred)	Owner name: ESPERION LUV DEVELOPMENT INC.
2005-01-19	A4	Supplementary search report drawn up and despatched	Effective date: 20041208
2005-07-27	17Q	First examination report despatched	Effective date: 20050609
2006-05-12	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2006-06-14	18D	Application deemed to be withdrawn	Effective date: 20051220
2008-12-19	REG	Reference to a national code	Ref country code: HK Ref legal event code: WD Ref document number: 1044897 Country of ref document: HK